OtherVC-backedMerged 2024
Oxford, United Kingdom · Founded 2012
Exscientia
Pharmatech for precision-designed drugs.
About Exscientia
UK AI-drug-design pioneer. Merger-completed with Recursion Pharmaceuticals in 2024.
Company facts
- Category
- Other
- Funding stage
- Merged 2024
- Total raised
- Public (NASDAQ: RXRX)
- Founded
- 2012
- Team size
- 501-1000
- HQ
- Oxford
- Country
- United Kingdom
- Website
- exscientia.ai
Founders of Exscientia
- Andrew Hopkins
Investors backing Exscientia
- SoftBank
- Novo Holdings
Frequently asked questions
What does Exscientia do?
UK AI-drug-design pioneer. Merger-completed with Recursion Pharmaceuticals in 2024.
Where is Exscientia based?
Exscientia is based in Oxford, United Kingdom.
When was Exscientia founded?
Exscientia was founded in 2012.
How much has Exscientia raised?
Exscientia has raised Public (NASDAQ: RXRX) in their Merged 2024 round.
Who founded Exscientia?
Exscientia was founded by Andrew Hopkins.
Who has invested in Exscientia?
Exscientia is backed by SoftBank, Novo Holdings.